Table of Contents

• 1.1 List of Tables 4
• 1.2 List of Figures 6

2 Introduction 7

• 2.1 Intra-Cranial Pressure (ICP) Monitoring Devices Overview 7

3 Products under Development 8

• 3.1 Intra-Cranial Pressure (ICP) Monitoring Devices - Pipeline Products by Stage of Development 8
• 3.2 Intra-Cranial Pressure (ICP) Monitoring Devices - Pipeline Products by Territory 9
• 3.3 Intra-Cranial Pressure (ICP) Monitoring Devices - Pipeline Products by Regulatory Path 10
• 3.4 Intra-Cranial Pressure (ICP) Monitoring Devices - Pipeline Products by Estimated Approval Date 11
• 3.5 Intra-Cranial Pressure (ICP) Monitoring Devices - Ongoing Clinical Trials 12

4 Intra-Cranial Pressure (ICP) Monitoring Devices - Pipeline Products under Development by Companies 13

• 4.1 Intra-Cranial Pressure (ICP) Monitoring Devices Companies - Pipeline Products by Stage of Development 13
• 4.2 Intra-Cranial Pressure (ICP) Monitoring Devices - Pipeline Products by Stage of Development 15

5 Intra-Cranial Pressure (ICP) Monitoring Devices Companies and Product Overview 16

• 5.1 Ad-Tech Medical Instrument Corp Company Overview 16
  • 5.1.1 Ad-Tech Medical Instrument Corp Pipeline Products & Ongoing Clinical Trials Overview 16
• 5.2 Boston Neurosciences Company Overview 17
  • 5.2.1 Boston Neurosciences Pipeline Products & Ongoing Clinical Trials Overview 17
• 5.3 City, University of London Company Overview 21
  • 5.3.1 City, University of London Pipeline Products & Ongoing Clinical Trials Overview 21
• 5.4 Columbia University Company Overview 22
  • 5.4.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 22
• 5.5 Drexel University Company Overview 23
  • 5.5.1 Drexel University Pipeline Products & Ongoing Clinical Trials Overview 23
• 5.6 Duke University Company Overview 24
  • 5.6.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 24
• 5.7 HeadSense Medical Ltd. Company Overview 25
  • 5.7.1 HeadSense Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 25
• 5.8 Integra LifeSciences Holdings Corp Company Overview 29
  • 5.8.1 Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview 29
• 5.9 Integrated Sensing Systems Inc Company Overview 30
  • 5.9.1 Integrated Sensing Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 30
• 5.10 Irras AB Company Overview 32
  • 5.10.1 Irras AB Pipeline Products & Ongoing Clinical Trials Overview 32
• 5.11 Koronis Biomedical Technologies Corporation Company Overview 35
  • 5.11.1 Koronis Biomedical Technologies Corporation Pipeline Products & Ongoing Clinical Trials Overview 35
• 5.12 Neural Analytics, Inc. Company Overview 36
  • 5.12.1 Neural Analytics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
• 5.13 Neurallys Company Overview 37
  • 5.13.1 Neurallys Pipeline Products & Ongoing Clinical Trials Overview 37
• 5.14 NeuroDx Development, LLC Company Overview 38
  • 5.14.1 NeuroDx Development, LLC Pipeline Products & Ongoing Clinical Trials Overview 38
• 5.15 Nisonic AS Company Overview 39
  • 5.15.1 Nisonic AS Pipeline Products & Ongoing Clinical Trials Overview 39
• 5.16 Northwestern University Company Overview 40
  • 5.16.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 40
• 5.17 Orsan Medical Technologies Ltd. Company Overview 41
  • 5.17.1 Orsan Medical Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview 41
• 5.18 Qura Inc Company Overview 42
  • 5.18.1 Qura Inc Pipeline Products & Ongoing Clinical Trials Overview 42
• 5.19 Remote Vital Monitoring Inc Company Overview 43
  • 5.19.1 Remote Vital Monitoring Inc Pipeline Products & Ongoing Clinical Trials Overview 43
• 5.20 Stanford University Company Overview 44
  • 5.20.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 44
• 5.21 The Feinstein Institute for Medical Research Company Overview 45
  • 5.21.1 The Feinstein Institute for Medical Research Pipeline Products & Ongoing Clinical Trials Overview 45
• 5.22 Third Eye Diagnostics, Inc. Company Overview 46
  • 5.22.1 Third Eye Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 46
• 5.23 University of Illinois Company Overview 47
  • 5.23.1 University of Illinois Pipeline Products & Ongoing Clinical Trials Overview 47
• 5.24 Virginia Commonwealth University Company Overview 48
  • 5.24.1 Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview 48
• 5.25 Vivonics Inc Company Overview 49
  • 5.25.1 Vivonics Inc Pipeline Products & Ongoing Clinical Trials Overview 49
• 5.26 Washington University in St Louis Company Overview 50
  • 5.26.1 Washington University in St Louis Pipeline Products & Ongoing Clinical Trials Overview 50
• 5.27 Wisconsin Institute of Nuclear Systems Company Overview 51
  • 5.27.1 Wisconsin Institute of Nuclear Systems Pipeline Products & Ongoing Clinical Trials Overview 51

6 Intra-Cranial Pressure (ICP) Monitoring Devices - Recent Developments 52

• 6.1 Nov 21, 2019: IRRAS announces FDA clearance of new 510(K) filing to expand the time of use of IRRAflow 52
• 6.2 Nov 18, 2019: Nisonic Demonstrates Automatic Measurements of Optic Nerve Sheath Diameter as a Marker for Increased Intracranial Pressure Using Transorbital Ultrasound at Medica In Düsseldorf, Germany 52
• 6.3 Nov 07, 2019: Penumbra reports third quarter 2019 financial results 53
• 6.4 Oct 24, 2019: Integra LifeSciences reports third quarter 2019 financial results 53
• 6.5 Oct 18, 2019: IRRAS announces participation at the 69th Congress of Neurological Surgeons’ Annual Meeting (CNS 2019) 54

7 Appendix 69

• 7.1 Methodology 69
• 7.2 About GlobalData 72
• 7.3 Contact Us 72

Intra-Cranial Pressure (ICP) Monitoring Devices - Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, “Intra-Cranial Pressure (ICP) Monitoring Devices - Medical Devices Pipeline Assessment, 2019" provides an overview of Intra-Cranial Pressure (ICP) Monitoring Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Intra-Cranial Pressure (ICP) Monitoring Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Intra-Cranial Pressure (ICP) Monitoring Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Intra-Cranial Pressure (ICP) Monitoring Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Intra-Cranial Pressure (ICP) Monitoring Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date